Device type · LSL
Dna-Reagents, Neisseria
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LSL
Microbiology
Device class
Class II
FDA decisions since 2015
5
510(k), De Novo and PMA
Adverse event reports
59
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Dna-Reagents, Neisseria
- Product code
- LSL
- Device class
- Class II
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3390
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for LSL
Latest FDA decisions
K231329 · Decided Jan 26, 2024 · 263 days after receipt
Device type: Dna-Reagents, Neisseria (LSL) · Laboratory Medicine & Pathology
K180681 · Decided Jun 13, 2018 · 90 days after receipt
Device type: Dna-Reagents, Neisseria (LSL) · Laboratory Medicine & Pathology
K173887 · Decided Mar 21, 2018 · 90 days after receipt
Device type: Dna-Reagents, Neisseria (LSL) · Laboratory Medicine & Pathology
- Xpert CT/NG510(k)
K173840 · Decided Mar 16, 2018 · 88 days after receipt
Device type: Dna-Reagents, Neisseria (LSL) · Laboratory Medicine & Pathology
- cobas® CT/NG v2.0 Test510(k)
K163184 · Decided Feb 9, 2017 · 87 days after receipt
Device type: Dna-Reagents, Neisseria (LSL) · Laboratory Medicine & Pathology
Reports received
59
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
44
75% of reports
Injury reports
15
25% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 3 | 0 | 0 | 0 |
| Apr 24 | 1 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 2 | 1 | 0 | 0 |
| Oct 24 | 0 | 1 | 0 | 0 |
| Nov 24 | 1 | 1 | 0 | 0 |
| Dec 24 | 6 | 1 | 0 | 0 |
| Jan 25 | 0 | 1 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 | 0 |
| Mar 25 | 1 | 1 | 0 | 0 |
| Apr 25 | 5 | 0 | 0 | 0 |
| May 25 | 0 | 3 | 0 | 0 |
| Jun 25 | 1 | 3 | 0 | 0 |
| Jul 25 | 1 | 5 | 0 | 0 |
| Aug 25 | 0 | 3 | 0 | 0 |
| Sep 25 | 1 | 2 | 0 | 0 |
| Oct 25 | 0 | 5 | 0 | 0 |
| Nov 25 | 2 | 3 | 0 | 0 |
| Dec 25 | 3 | 1 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 1 | 1 | 0 | 0 |
| Mar 26 | 5 | 0 | 0 | 0 |
| Apr 26 | 17 | 1 | 0 | 0 |
| May 26 | 3 | 2 | 0 | 0 |
| Jun 26 | 7 | 2 | 0 | 0 |
| Jul 26 | 0 | 2 | 0 | 0 |
| Aug 26 | 4 | 0 | 0 | 0 |
| Sep 26 | 0 | 2 | 0 | 0 |
| Oct 26 | 2 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Hologic17
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- False Positive Result32
- Imprecise or Erratic Results11
- False Negative Result7
- Incorrect, Inadequate or Imprecise Result or Readings7
- Off-Label Use2
- Contamination1
- Insufficient Device Problem Information1
- Leak/Splash1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions59
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0592-2018 · Started Oct 9, 2017
Reason given: Cepheid has received reports that some of our customers have experienced a higher number of temperature drift errors than would typically be expected when using this test and its intended use specimen types. Investigation of the issue also revealed an occasional probability of false negative results which remains...
Cause as FDA categorized it: Equipment maintenance
Z-2431-2015 · Started Jul 27, 2015 · Posted by FDA Aug 20, 2015
Reason given: Firm determined that some lots of CT/NG Swab 50 and CT/NG Urine collection kits contain a sub component with an expiry date that is earlier than the kit expiration date.
Cause as FDA categorized it: Incorrect or no expiration date
Z-2432-2015 · Started Jul 27, 2015 · Posted by FDA Aug 20, 2015
Reason given: Firm determined that some lots of CT/NG Swab 50 and CT/NG Urine collection kits contain a sub component with an expiry date that is earlier than the kit expiration date.
Cause as FDA categorized it: Incorrect or no expiration date
Z-0455-05 · Started Jan 10, 2005 · Posted by FDA Feb 3, 2005
Reason given: An in-vitro diagnostic kit reagent may cause false negative clinical results in patients tested for sexually transmitted infections.
Cause as FDA categorized it: Other
Z-1361-04 · Started Jul 7, 2004 · Posted by FDA Aug 19, 2004
Reason given: An increased frequency of 'blue foci' that potentially can cause elevated A450 background in microwell plate wells after the addition of conjugate reagent during PCR detection.
Cause as FDA categorized it: Other
Z-1368-04 · Started Jul 7, 2004 · Posted by FDA Aug 19, 2004
Reason given: An increased frequency of 'blue foci' that potentially can cause elevated A450 background in microwell plate wells after the addition of conjugate reagent during PCR detection.
Cause as FDA categorized it: Other
Z-1094-03 · Started Jul 21, 2003 · Posted by FDA Aug 20, 2003
Reason given: Component of in vitro diagnostic device was incorrectly installed causing incorrect reporting of patient results.
Cause as FDA categorized it: Other
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.